Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 2033-2039

  Maimon, Y ^a,b   Karaush, V ^a   Yaal Hahoshen, N ^a   Ben Yosef, R ^a   Ron, I ^a   Vexler, A ^a   Lev Ari, S ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Refuot Medical Centre   (Israel)

Author keywords

Apoptosis; Breast cancer; Chinese herbs; Facs analysis; Mda 231; Mda 453; T47d

Indexed keywords

ASTRALAGUS MEMBRANACEUS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; CHINESE DRUG; GLEHNIA LITTORALIS EXTRACT; HERBACEOUS AGENT; LIGUSTRUM LUCIDUM EXTRACT; LYCIUM CHINENSE EXTRACTP; MANDARIN EXTRACT; MILLETIA RETICULATA EXTRACT; OLDENLANDIA DIFFUSA EXTRACT; OPHIOPOGON JAPONICUS EXTRACT; PAEONIA LACTIFLORA EXTRACT; PAEONIA OBOVATA EXTRACT; PORIAE COCOS EXTRACT; PRUNELLA VULGARIS EXTRACT; SCUTELLARIA BARBATA EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTRALAGUS MEMBRANACEUS; ATRACTYLODES MACROCEPHALA; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENCE ACTIVATED CELL SORTING; GLEHNIA LITTORALIS; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYCIUM CHINENSE; MEDICINAL PLANT; MILLETIA RETICULATA; OLDENLANDIA DIFFUSA; OPHIOPOGON JAPONICUS; PAEONIA LACTIFLORA; PAEONIA OBOVATA; PORIAE COCOS; PRUNELLA VULGARIS; SCUTELLARIA BARBATA;

EID: 78650810185     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800617     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, et al: Estimates of worldwide burden of cancer in2008: GLOBOCAN 2008. Int J Cancer 2010; epub ahead of print.
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Cragg GM, Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol 2005; 100: 72-79.
4. Richardson MA, Sanders T, Palmer JL, et al: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505-2514.
5. Bernstein BJ, Grasso T: Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park) 2001; 15: 1267-1272.
6. Molassiotis A, Scott JA, Kearney N, et al: Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006; 14: 260-267.
7. Boon H, Wong J: Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 2004; 5: 2485-2501.
8. Campbell MJ, Hamilton B, Shoemaker M: Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res 2002; 22: 3843-3852.
9. Shoemaker M, Hamilton B, Dairkee SH, et al: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 2005; 19: 649-651.
10. Zhu K, Fukasawa I, Furuno M, et al: Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol 2005; 97: 405-409.
11. Vexler AM, Mou X, Gabizon AA, et al: Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 1995; 60: 611-615.
12. Gorodetsky R, Mou X, Pfeffer MR, et al: Sub- additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines. Isr J Med Sci 1995; 31: 95-100.
13. Gorodetsky R, Levy-Agababa F, Mou X, et al: Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Int J Cancer 1998; 75: 635-642.
14. Zhang M, Chiu LC, Cheung PC, et al: Growth- inhibitory effects of a β-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction. Oncol Rep 2006; 15: 637-643.
15. Zhang HY, Ge N, Zhang ZY: Theoretical elucidation of activity differences of five phenolic antioxidants. Zhongguo Yao Li Xue Bao 1999; 20: 363-366.
16. Nizamutdinova IT, Oh HM, Min YN, et al: Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor- α-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-κB signaling pathways. Int Immunopharmacol 2007; 7: 343-350.
17. Karin M: Nuclear factor-κB in cancer development and progression. Nature 2006; 441: 431-436.
18. Dan B, Andrew G: Chinese Herbal Medicine, 8th edn. Seattle: Eastland Press, 1986; pp 334-335.
19. Tian Q, Miller EG, Ahmad H, et al: Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 2001; 40: 180-184.
20. Manthey JA, Guthrie N: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 2002; 50: 5837-5843.
21. Kang SA, Park HJ, Kim MJ, et al: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol 2005; 97: 231-235.
22. Gupta S, Zhang D, Yi J, et al: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother 2004; 4: 21-33.
23. Yoshida Y, Wang MQ, Liu JN, et al: Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 1997; 19: 359-370.
24. Wong BY, Lau BH, Jia TY, et al: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biother Radiopharm 1996; 11: 51-56.
25. Yin X, Zhou J, Jie C, et al: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004; 75: 2233-2244.
26. Yao H, Li S, Hu J, et al: Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata. Planta Med 2010; epub ahead of print.
27. Rugo H, Shtivelman E, Perez A, et al: Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 2007; 105: 17-28.
28. Liu F, Xie ZH, Cai GP, et al: The effect of survivin on multidrug resistance mediated by P- glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull 2007; 30: 2279-2283.
29. Meslin F, Hamaï A, Gao P, et al: Silencing of prion protein sensitizes breast adriamycin- resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res 2007; 67: 10910-10919.